Land This Bargain Even Cheaper Than Director Hagen Did
September 14, 2021 at 12:00 PM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 2, ZIOPHARM Oncology Inc's Director, Heidi Hagen, invested $41,835.20 into 23,770 shares of ZIOP, for a cost per share of $1.76..